Journal article
Antibodies that block or activate mouse b cell activating factor of the tumor necrosis factor (TNF) family (baff), respectively, induce b cell depletion or b cell hyperplasia
C Kowalczyk-Quintas, S Schuepbach-Mallepell, M Vigolo, L Willen, A Tardivel, CR Smulski, TS Zheng, J Gommerman, H Hess, JE Gottenberg, F Mackay, O Donze, P Schneider
Journal of Biological Chemistry | AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC | Published : 2016
Abstract
B cell activating factor of the TNF family (BAFF), also known as B lymphocyte stimulator, is a ligand required for the generation and maintenance of B lymphocytes. In this study, the ability of different monoclonal antibodies to recognize, inhibit, or activate mouse BAFF was investigated. One of them, a mouse IgG1 named Sandy-2, prevented the binding of BAFF to all of its receptors, BAFF receptor, transmembrane activator and calcium modulating ligand interactor, and B cell maturation antigen, at a stoichiometric ratio; blocked the activity of mouse BAFF on a variety of cell-based reporter assays; and antagonized the prosurvival action of BAFF on primary mouse B cells in vitro. A single admin..
View full abstractGrants
Awarded by Merck
Funding Acknowledgements
This work was supported in part by grants from the Swiss National Science Foundation (to P. S.) and the Commission for Technology and Innovation (to P. S. and O. D.). P. S. is supported by a research grant from EMD Serono, a subsidiary of Merck, KGaA. H. H. is an employee of Merck, KGaA. T. S. Z. is an employee of Biogen. O. D. is chief scientific officer at Adipogen Life Sciences.